Leukemia is diagnosed through a combination of blood tests, bone marrow sampling, and specialized lab analysis that together confirm whether abnormal cells are present and identify the exact type. The process typically begins with a routine blood draw and, if results are concerning, moves quickly to more detailed testing. Most people receive a definitive diagnosis within a few weeks of their first abnormal blood test.
Physical Exam and Early Signs
Before any lab work, a doctor performs a physical exam looking for visible signs that something is off with blood cell production. Pale skin suggests anemia from low red blood cell counts. Swollen lymph nodes in the neck, armpits, or groin can signal abnormal white blood cell activity. The doctor will also feel your abdomen for an enlarged liver or spleen, both of which can swell when leukemia cells accumulate there. Tiny red or purple spots on the skin, called petechiae, point to low platelet counts and poor clotting.
None of these findings alone confirm leukemia. Many other conditions cause similar symptoms. But when several appear together, they prompt the blood tests that move the diagnosis forward.
What Blood Tests Reveal
A complete blood count (CBC) is usually the first test ordered. It measures white blood cells, red blood cells, and platelets. In leukemia, one or more of these values is abnormal, but the pattern varies widely. About half of children with the most common type of childhood leukemia (acute lymphoblastic leukemia) show white blood cell counts below 11,000 per microliter, which falls within or near the normal range. Others present with dramatically elevated counts above 50,000, 100,000, or even 200,000.
This is an important point: there is no single “leukemia number” on a blood test. A normal platelet count does not rule out leukemia. Neither does the absence of anemia. When all three cell lines are low simultaneously, a condition called pancytopenia, that’s treated as a medical emergency requiring immediate evaluation. But the CBC alone cannot diagnose leukemia. It raises the alarm.
If the CBC looks suspicious, a pathologist examines a blood smear under a microscope. They’re looking for blast cells, which are immature blood cells that normally stay inside the bone marrow. These cells are visibly different from mature blood cells: they’re large, with a high ratio of nucleus to surrounding cell material, fine-textured genetic material inside the nucleus, and very little cytoplasm. Finding blasts circulating in the bloodstream is a strong indicator that the bone marrow is producing abnormal cells, and it triggers the next step.
Bone Marrow Biopsy: The Definitive Test
A bone marrow biopsy is the test that confirms or rules out leukemia. It collects cells directly from the source, giving doctors a clear picture of what the marrow is producing.
The sample is almost always taken from the back of the hipbone (the posterior iliac crest). Occasionally the front of the hip is used instead, and in infants under about 18 months, doctors sometimes draw marrow from the lower leg bone. Two samples are collected during the same procedure. First, a hollow needle is inserted through a small skin incision into the bone, and a syringe withdraws liquid marrow (the aspiration). Then a slightly larger needle extracts a small cylindrical core of solid marrow tissue (the biopsy).
The procedure is done with local anesthesia and sometimes sedation. Most people describe a deep pressure or aching sensation when the marrow is drawn. The whole process takes about 30 minutes, and you can typically go home the same day.
Pathologists examine both samples under the microscope, counting the percentage of blast cells. For a diagnosis of acute myeloid leukemia (AML) without a known genetic abnormality, international guidelines generally require at least 20% blasts in the marrow or blood. When certain specific genetic mutations are present, the diagnosis can be made with lower blast percentages, even as low as 10% under some classification systems.
Flow Cytometry and Cell Identification
Once leukemia is suspected, a technology called flow cytometry helps determine exactly what type it is. This test works by passing individual cells through a laser beam one at a time, measuring their size, internal complexity, and which proteins sit on their surface.
Every type of blood cell carries a unique combination of surface proteins. Leukemia cells carry their own distinct patterns that differ from normal cells in predictable ways. Some proteins are abnormally high or low. Others appear on cells that shouldn’t have them at all. For instance, a protein normally found only on immune T-cells might show up on B-cells in certain types of chronic lymphocytic leukemia.
Flow cytometry can distinguish between leukemia arising from different cell lines. B-cell leukemias carry one set of markers, T-cell leukemias carry another, and myeloid leukemias carry yet another. This distinction matters because treatment approaches differ significantly between subtypes. The test processes thousands of cells per second, so results are available relatively quickly compared to genetic testing.
Genetic and Chromosomal Testing
After confirming that leukemia cells are present, doctors need to know what’s driving them. Genetic testing looks for specific chromosomal abnormalities and gene mutations that influence both prognosis and treatment choices.
Two key techniques are used. FISH (fluorescence in situ hybridization) uses fluorescent probes that attach to specific regions of chromosomes, lighting up when a translocation or rearrangement is present. It’s particularly valuable for detecting the Philadelphia chromosome, a hallmark of chronic myeloid leukemia created when parts of two chromosomes swap places and produce an abnormal protein that drives uncontrolled cell growth. In comparative studies, FISH detected this translocation in 100% of positive cases, making it extremely reliable.
PCR (polymerase chain reaction) amplifies tiny amounts of genetic material so mutations can be detected even when very few abnormal cells are present. It’s considered the most sensitive tool for finding the Philadelphia chromosome translocation and is widely used alongside other methods. However, it occasionally produces false-positive results, occurring in about 5% of cases in one study, which is why doctors often use FISH to confirm findings.
These genetic results take longer than other tests. While a CBC comes back within hours and a bone marrow morphology report may take a few days, the full genetic workup can take a few weeks.
Imaging Tests
Imaging doesn’t diagnose leukemia itself but helps doctors understand how far it has spread. Chest X-rays, ultrasounds, CT scans, MRIs, and PET scans can reveal whether leukemia cells have affected bones, kidneys, the brain, or lymph nodes throughout the body. Not every patient needs every type of scan. The choice depends on symptoms, the type of leukemia suspected, and what the blood and marrow results show.
Spinal Fluid Analysis
For certain types of leukemia, particularly acute lymphoblastic leukemia, doctors perform a lumbar puncture (spinal tap) to check whether leukemia cells have reached the central nervous system. A needle is inserted into the lower spine to collect a small amount of cerebrospinal fluid, which is then examined for blast cells.
The results are classified into categories. CNS-1 means no blast cells were found. CNS-2 means blast cells are present but in very low numbers (fewer than 5 white blood cells per microliter of fluid). CNS-3 indicates a higher concentration of blast cells and confirms central nervous system involvement. This classification directly affects treatment intensity, since leukemia that has reached the brain and spinal cord requires additional targeted therapy delivered directly into the spinal fluid.
Doctors sometimes delay the lumbar puncture by several days after diagnosis to stabilize the patient first, using blood transfusions, antibiotics, and initial treatment to reduce the number of circulating blast cells. This approach helps avoid accidentally introducing leukemia cells into the spinal fluid during the procedure itself.
How Long the Full Workup Takes
The diagnostic timeline varies by test. A CBC result is typically available the same day or the next morning. Bone marrow morphology, where a pathologist examines the cells under a microscope, usually takes a few days. Flow cytometry results arrive within a similar timeframe. The slowest piece is genetic testing, which can take two to three weeks for the complete picture.
In practice, doctors often have enough information from the blood smear, bone marrow, and flow cytometry to begin treatment before all genetic results are back. The genetic data then refines the diagnosis and may adjust the treatment plan once it arrives. For acute leukemias, where rapid cell growth makes time critical, this staged approach means treatment can start within days of the first bone marrow biopsy rather than waiting weeks for every test to finalize.